Targeting ligands are molecules attached to the surface of nanocarriers that bind to specific receptors on target cells. This ensures that the drug-loaded nanoparticles are delivered precisely to the diseased cells, sparing healthy tissues. Common ligands include antibodies, peptides, and small molecules that recognize cell surface markers.
